Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten analysts that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average […]
FY2024 EPS Estimates for BridgeBio Pharma, Inc. (NASDAQ:BBIO) Reduced by Analyst themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ten research firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) was the recipient of unusually large options trading on Monday. Stock investors purchased 10,304 call options on the stock. This is an increase of approximately 43% compared to the typical volume of 7,221 call options. Analyst Upgrades and Downgrades A number of equities research analysts have issued […]
BridgeBio Pharma (NASDAQ:BBIO) PT Raised to $42.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.